DiaMedica Therapeutics Inc.

DMAC Stock Healthcare Biotechnology
$6.39
-0.36 (-5.33%)
Price as of Aug 28, 2026 market close

Performance

1 Month
-1.8%
3 Months
+6.7%
YTD
-19.7%
1 Year
+6.9%

Price return, based on split- and dividend-adjusted closing prices.

Risk

Volatility 1-year annualized
59.3%
Largest decline max drawdown, since Aug 2025
-43.2%
Risk-adjusted return Sharpe ratio, 1-year
0.40

Own DMAC?

See how DMAC contributes to your portfolio's return, allocation, and risk.

7-day free trial, then $9/month.